876143-74-7 Usage
Uses
Used in Pharmaceutical Industry:
(2-thiophen-3-ylphenyl)carbamic acid 1-[2-(4-[(R)-2-(tert-butyldimethyl-silanyloxy)-2-(8-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl-3-methoxyphenylcarbamoyl)ethyl]piperidin-4-yl ester is used as a pharmaceutical compound for its potential therapeutic applications. Its complex structure and various functional groups may contribute to its ability to interact with biological targets and exhibit pharmacological effects.
Used in Chemical Research:
(2-thiophen-3-ylphenyl)carbamic acid 1-[2-(4-[(R)-2-(tert-butyldimethyl-silanyloxy)-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl-3-methoxyphenylcarbamoyl)ethyl]piperidin-4-yl ester is also used in chemical research for studying the synthesis and properties of complex organic molecules. Its unique structure and functional groups provide opportunities for investigating new synthetic routes, understanding its reactivity, and exploring its potential applications in various fields.
Used in Drug Development:
(2-thiophen-3-ylphenyl)carbamic acid 1-[2-(4-[(R)-2-(tert-butyldimethyl-silanyloxy)-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl-3-methoxyphenylcarbamoyl)ethyl]piperidin-4-yl ester can be used in drug development for designing and optimizing new therapeutic agents. Its diverse functional groups and substituents may offer opportunities for modifying its properties and improving its efficacy as a drug candidate.
Check Digit Verification of cas no
The CAS Registry Mumber 876143-74-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,6,1,4 and 3 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 876143-74:
(8*8)+(7*7)+(6*6)+(5*1)+(4*4)+(3*3)+(2*7)+(1*4)=197
197 % 10 = 7
So 876143-74-7 is a valid CAS Registry Number.
876143-74-7Relevant academic research and scientific papers
Compounds having beta adrenergic receptor agonist and muscarinic receptor antagonist activity
-
Page/Page column 34, (2008/06/13)
This invention provides compounds of formula I: wherein R1, R2, R4, R5, R6, R7, R8a, R8b, W, a, b, c and m are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The compounds of this invention possess both β2 adrenergic receptor agonist and muscarinic receptor antagonist activity. Accordingly, such compounds are expected to be useful as therapeutic agents for treating pulmonary disorders, such as chronic obstructive pulmonary disease and asthma.
